The Challenges in Managing Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

about

The Challenges in Managing Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Item

http://www.wikidata.org/entity/Q36721773

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@ast

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@en

type

Item

label

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@ast

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@en

prefLabel

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@ast

The Challenges in Managing Pul ...... with Congenital Heart Disease.

@en

P1476

The Challenges in Managing Pul ...... with Congenital Heart Disease

@en

P2093

Chun-Wei Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance.

Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy.

Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?

Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease.

Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies.

Approaching atrial septal defects in pulmonary hypertension.

Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.

P304

516-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.6515/ACS20151014A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27122916

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

P932

4804976

http://www.w3.org/2001/XMLSchema#string